Flonase Indirect Purchasers Sue SmithKline Beecham

Law360, New York (August 22, 2008, 12:00 AM EDT) -- Legal problems continue to stack up against SmithKline Beecham Corp., which faces another proposed class action for allegedly stalling the approval of a generic version of Flonase, the drugmaker's blockbuster nasal allergy medication.

The lawsuit, filed by Alabama-based AF Of L-AGC Building Trades Welfare Plan in the U.S. District Court for the Eastern District of Pennsylvania on Thursday, follows the filing of a similar suit by the IBEW–NECA Local 505 Health & Welfare Plan last month.

The latest proposed class action of indirect purchasers of Flonase...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.